{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:39:30Z","timestamp":1740155970166,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/nrurol.2015.282","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T05:57:49Z","timestamp":1448949469000},"page":"72-74","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HIV protection with PrEP \u2014 implications for controlling other STIs"],"prefix":"10.1038","volume":"13","author":[{"given":"Douglas S.","family":"Krakower","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth H.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"key":"BFnrurol2015282_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/cid\/civ289","volume":"61","author":"P Pathela","year":"2015","unstructured":"Pathela, P., Braunstein, S. L., Blank, S., Shepard, C. & Schillinger, J. A. The high risk of an HIV diagnosis following a diagnosis of syphilis: a population-level analysis of New York City men. Clin. Infect. Dis. 61, 281\u2013287 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrurol2015282_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten, J. M.  et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N. Engl. J. Med. 367, 399\u2013410 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrurol2015282_CR3","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant, R. M.  et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N. Engl. J. Med. 363, 2587\u20132599 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrurol2015282_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen, M. C.  et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N. Engl. J. Med. 367, 423\u2013434 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrurol2015282_CR5","doi-asserted-by":"publisher","unstructured":"McCormack, S.  et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet \n                    http:\/\/dx.doi.org\/10.1016\/S0140-6736(15)00056-2\n                    \n                   (2015).","DOI":"10.1016\/S0140-6736(15)00056-2"},{"key":"BFnrurol2015282_CR6","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/cid\/civ778","volume":"61","author":"JE Volk","year":"2015","unstructured":"Volk, J. E.  et al. No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clin. Infect. Dis. 61, 1601\u20131603 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrurol2015282_CR7","doi-asserted-by":"publisher","first-page":"e1001777","DOI":"10.1371\/journal.pmed.1001777","volume":"12","author":"MR Golden","year":"2015","unstructured":"Golden, M. R.  et al. Uptake and population-level impact of expedited partner therapy (EPT) on Chlamydia trachomatis and Neisseria gonorrhoeae: the Washington State community-level randomized trial of EPT. PLoS Med. 12, e1001777 (2015).","journal-title":"PLoS Med."},{"key":"BFnrurol2015282_CR8","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1056\/NEJMc1408109","volume":"371","author":"MM Lahra","year":"2014","unstructured":"Lahra, M. M., Ryder, N. & Whiley, D. M. A new multidrug-resistant strain of Neisseria gonorrhoeae in Australia. N. Engl. J. Med. 371, 1850\u20131851 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFnrurol2015282_CR9","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/cid\/civ478","volume":"61","author":"EW Hook 3rd","year":"2015","unstructured":"Hook, E. W. 3rd  et al. A Phase 2 trial of oral solithromycin 1200 mg or 1000 mg as single-dose oral therapy for uncomplicated gonorrhea. Clin. Infect. Dis. 61, 1043\u20131048 (2015).","journal-title":"Clin. Infect. Dis."},{"key":"BFnrurol2015282_CR10","unstructured":"Centers for Disease Control and Prevention. 2015 Sexually Transmitted Diseases Treatment Guidelines \n                    [online]\n                    \n                  , (2015)."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2015.282.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2015.282","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2015.282.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:13:36Z","timestamp":1684469616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrurol.2015.282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,1]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["BFnrurol2015282"],"URL":"https:\/\/doi.org\/10.1038\/nrurol.2015.282","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"type":"print","value":"1759-4812"},{"type":"electronic","value":"1759-4820"}],"subject":[],"published":{"date-parts":[[2015,12,1]]},"assertion":[{"value":"1 December 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.S.K. and K.H.M. have conducted research with project support from Gilead Sciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}